Will Pih

Will Pih is the current Principal and EVP of Specialty Commercialization at Two Labs. Will has over 25 years of experience in the pharmaceutical and medical device industries. Will has held various leadership positions at companies such as Amgen, Roche, and BioSys Laboratories, Inc.

Will Pih founded BioSys Laboratories, Inc. in 1991, a medical device company focused on point-of-care devices. Under their leadership, the company developed Covid-19 PCR and Serology tests, among other products. Will also negotiated and implemented the first contract in the history of start-up oncology GPO called ION at Roche/Genentech.

In their current role at Two Labs, Will is responsible for specialty commercialization, including developing and executing strategies to grow revenue and market share. Will has successfully launched multiple products in the United States and Europe across a variety of therapeutic areas.

Will Pih is an undergraduate economics major at the University of Southern California. Will is also a graduate student in the Doctor of Pharmacy - PharmD program at USC. In addition, they are a pharmaceutical science student at USC.

They are on a team with and Angela Hoyt - SVP, Commercialization. Their manager is Darius Naigamwalla, CCO.